Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphatidylcholine lipid bilayer is the primary structural matrix of eukaryotic cell membranes, composed of amphipathic phospholipids with a choline head group and two fatty acid tails (Alberts et al., Molecular Biology of the Cell, 2002). It functions as a selective permeability barrier, maintaining the distinct internal environment of cells and organelles while facilitating the localization and function of membrane-bound proteins (van Meer et al., Nature Reviews Molecular Cell Biology, 2008). In pathophysiology, changes in the composition or fluidity of the PC bilayer are associated with conditions such as respiratory distress syndrome, where surfactant deficiency leads to alveolar collapse, and various metabolic disorders (Agassandian & Mallampalli, Biochimica et Biophysica Acta, 2013). Therapeutic interventions often target the bilayer to either disrupt it, as seen with certain antimicrobial peptides and antifungal agents like Amphotericin B, or to restore its function through lipid replacement therapies (Yeaman & Yount, Pharmacological Reviews, 2003; Escribá et al., Journal of Cellular and Molecular Medicine, 2008). Additionally, the PC bilayer is a critical component in the formulation of liposomal drug delivery systems, which enhance the bioavailability and reduce the toxicity of encapsulated drugs (van Meer et al., 2008). Understanding the biophysical properties of this bilayer is essential for developing treatments that modulate membrane-associated signaling pathways and cellular stability (Escribá et al., 2008).
Membrane disruption, pore formation, and membrane stabilization (Yeaman & Yount, 2003; Escribá et al., 2008)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylcholine lipid bilayer (PC bilayer).